Cargando…
Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure
BACKGROUND: A vero cell-based inactivated Rabies Vaccine (Rabivax-S) and Rabies Human Monoclonal Antibody (Rabishield) have been approved since 2016. A post-marketing surveillance was conducted in India from 2020 to 2021 to gather real world safety data on Rabivax-S and Rabishield. METHODS: This was...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363514/ https://www.ncbi.nlm.nih.gov/pubmed/37492421 http://dx.doi.org/10.1016/j.lansea.2023.100207 |